Compared with benign lung disease patients, the serum level of Hsp90α (128.23 ng/mL, ranging from 76.40 to 167.20 ng/mL) in lung cancer patients was higher (p < 0.0001, Figure 1A). This evidence concerns the gene HSP90AA1 and lung cancer.